Stock listing
Novolog (pharm Up 1966) Ltd.
Selected listing: NVLG · TASE · ILA · IL
Novolog (pharm Up 1966) Ltd. (TASE:NVLG), Distribution Services. Latest release Mar 23, 2026: NVLG: Revenue fell and net loss recorded in 2025, mainly due…
- Ticker
- TASE:NVLG
- Asset type
- Stock
- Sector
- Distribution Services
- Industry
- Medical Distributors
- Exchange
- TASE
- Currency
- ILA
About Novolog (pharm Up 1966) Ltd.
Novolog (pharm Up 1966) Ltd. is a public company based in Israel, trading under the ticker NVLG. Novolog specializes in pharmaceutical products and is focused on advancing healthcare solutions.
Latest news from Novolog (pharm Up 1966) Ltd.
NVLG: Revenue fell and net loss recorded in 2025, mainly due to SAP rollout disruptions in logistics
March 23, 2026
NVLG: Q3 2025 revenue and profit declined year-over-year, but all segments remained profitable
November 24, 2025
NVLG: Revenue and profit rose, but SAP rollout and war caused disruptions; dividend declared
August 19, 2025
NVLG: Revenue up, net income surged, but SAP rollout caused one-time costs and legal exposure
May 29, 2025
NVLG: Novolog achieved double-digit revenue growth and resumed profitability in 2024
March 25, 2025
Research Novolog (pharm Up 1966) Ltd.
Novolog (pharm Up 1966) Ltd. company profile
View the public company page for Novolog (pharm Up 1966) Ltd. on 6ix.
Novolog (pharm Up 1966) Ltd. news
Read company news and market updates connected to Novolog (pharm Up 1966) Ltd..
Novolog (pharm Up 1966) Ltd. investor events
Find investor webinars, events, and replay context for Novolog (pharm Up 1966) Ltd..